NCT01305200 · OUTCOME
Incidence of Severe Oral Mucositis
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- percent of patients
- Interval / dispersion
- Not reported
- Time frame
- Day -1 (day prior to stem cell infusion) to Day 20 following transplantation.
What was measured
Percentage of patients with Severe Oral Mucositis (WHO Grade 3 or 4) per arm.
Analysis population: Evaluable patients defined as patients with \>= 11 daily WHO assessments.
Groups in this outcome
Arm I (Placebo)
Patients rinse and gargle with placebo over 1 minute QID beginning the first day (about day -7) of the conditioning regimen. Treatment continues until day 20 post-transplantation. placebo: Mouth rinse questionnaire administration: Ancillary studies quality-of-life assessment: Ancillary studies
Arm II (Supersaturated Calcium Phosphate Rinse)
Patients rinse and gargle with supersaturated calcium phosphate rinse over 1 minute QID beginning on the first day (about day -7) of the conditioning regimen. Treatment continues until day 20 post-transplantation. supersaturated calcium phosphate rinse: Mouth rinse questionnaire administration: Ancillary studies quality-of-life assessment: Ancillary studies
| Group | Source count |
|---|---|
| Arm I (Placebo) | 91 |
| Arm II (Supersaturated Calcium Phosphate Rinse) | 91 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Arm I (Placebo) | 68 | Not reported | Not reported | Not reported | Not reported |
| Arm II (Supersaturated Calcium Phosphate Rinse) | 63 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 68
- group Id
- OG001
- value
- 63
- denoms
- counts
- group Id
- OG000
- value
- 91
- group Id
- OG001
- value
- 91
- units
- Participants
- description
- Percentage of patients with Severe Oral Mucositis (WHO Grade 3 or 4) per arm.
- groups
- description
- Patients rinse and gargle with placebo over 1 minute QID beginning the first day (about day -7) of the conditioning regimen. Treatment continues until day 20 post-transplantation. placebo: Mouth rinse questionnaire administration: Ancillary studies quality-of-life assessment: Ancillary studies
- id
- OG000
- title
- Arm I (Placebo)
- description
- Patients rinse and gargle with supersaturated calcium phosphate rinse over 1 minute QID beginning on the first day (about day -7) of the conditioning regimen. Treatment continues until day 20 post-transplantation. supersaturated calcium phosphate rinse: Mouth rinse questionnaire administration: Ancillary studies quality-of-life assessment: Ancillary studies
- id
- OG001
- title
- Arm II (Supersaturated Calcium Phosphate Rinse)
- param Type
- NUMBER
- population Description
- Evaluable patients defined as patients with \>= 11 daily WHO assessments.
- reporting Status
- POSTED
- time Frame
- Day -1 (day prior to stem cell infusion) to Day 20 following transplantation.
- title
- Incidence of Severe Oral Mucositis
- type
- SECONDARY
- unit Of Measure
- percent of patients
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle